Show simple item record

dc.contributor.advisorMorera Herreras, Teresa
dc.contributor.advisorBoraud, Thomas
dc.contributor.authorGuilhemsang, Lise
dc.date2024-12-16
dc.date.accessioned2023-01-18T16:57:29Z
dc.date.available2023-01-18T16:57:29Z
dc.date.issued2022-12-16
dc.date.submitted2022-12-16
dc.identifier.urihttp://hdl.handle.net/10810/59351
dc.description.abstractBasal ganglia (BG) circuits are involved in different functions from movement control to cognitive/motivational processes. The loss of dopamine (DA) in these circuits triggers Parkinson's disease (PD). In addition to DA depletion, PD patients present an early serotonergic (5-HT)alteration at the level of the BG nuclei. 5-HT modulates the activity of BG circuitry by acting on a large variety of 5-HT receptor subtypes. Among them, the 5-HT2A receptor is expressed in both motor and associative/limbic territories of the BG nuclei being implicated in regulation of motor,executive and cognitive functions, as well as automatisms. In addition, 5-HT2A receptors may also play a role in diseases linked to BG dysfunction, such as PD.Firstly, we investigated the specific contribution of 5-HT2A receptors on the dynamic regulation of BG circuits. For that purpose, in vivo single-unit extracellular recordings of lateral and medial substantia nigra pars reticulata (SNr) neurons along with simultaneous electrical stimulation of themotor and mPF cortex were used. The results showed a topographical-dependent dissociation in the effects triggered by the 5-HT2A agonist TCB-2, which specifically increased the medial SNr neuronactivity and had preferential action on mPF cortical information processing through the striato-nigraldirect pathway. These findings provide novel evidence about the specific signature of 5-HT2A receptors on the dynamic regulation of BG circuits.Secondly, we focused on the study of BG dynamics in pathological conditions. In PD, dopaminergic therapy such as the administration of the precursor levodopa reduces the symptomatology and improves movement execution in the early stage of the disease, but quickly triggers abnormal and involuntary movements known as levodopa-induced dyskinesia (LID). LID is very debilitating andrefractory to any further drug treatment. Hence, understanding the neuronal mechanism underlyingLID is fundamental to develop new therapeutic strategies. Recent studies have shown that LID is caused by excessive neuronal activity in the striatum, however, how such striatal activity impacts BGdownstream circuits such as the external globus pallidus (GPe) to generate LID is still unknown. Inaddition, a subpopulation of GPe neurons called the arkypallidal (Arky-GPe) neurons, directly forma negative feedback loop with the striatum to powerfully control action inhibition in normal conditions. We used optical methods to monitor in vivo the calcium activity of Arky-GPe neurons across different motor and disease states. Having characterised the abnormal changes of activity, wethen used optogenetic manipulation to test their causal contribution to LID generation. We found that optogenetic reactivation of Arky-GPe neurons during LID reduces hyperkinetic behaviour and promotes normal-like motor behaviour. These results pave the way to understand the complex mechanisms involved in the generation and maintenance of LID.es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.subjectneuropathologyes_ES
dc.subjectpsychopharmacologyes_ES
dc.titleNetwork dynamic of Basal Ganglia circuits in normal and parkinsonian conditionses_ES
dc.typeinfo:eu-repo/semantics/doctoralThesises_ES
dc.rights.holder(c) 2022 Lise Guilhemsang
dc.identifier.studentID976172es_ES
dc.identifier.projectID22338es_ES
dc.departamentoesFarmacologíaes_ES
dc.departamentoeuFarmakologiaes_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record